Comparison of seven CD19 CAR designs in engineering NK cells for enhancing anti-tumour activity.
Wang Y, Li J, Wang Z, Liu Y, Wang T, Zhang M, Xia C, Zhang F, Huang D, Zhang L, Zhao Y, Liu L, Zhu Y, Qi H, Zhu X, Qian W, Hu F, Wang J.
Wang Y, et al. Among authors: zhang l, zhang m, zhang f.
Cell Prolif. 2024 Nov;57(11):e13683. doi: 10.1111/cpr.13683. Epub 2024 Jun 3.
Cell Prolif. 2024.
PMID: 38830795
Free PMC article.